Z-521 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
238	ビタミンＤ抵抗性くる病/骨軟化症	2

238. ビタミンＤ抵抗性くる病/骨軟化症

---

臨床試験数 : 28 /  薬物数 : 20 - (DrugBank : 9) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 16

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-101332	01/9/2010	02/11/2010	Therapeutic use of Z-521	Therapeutic use of oral sodium phosphate (Z-521) in primary hypophosphatemic rickets (familial rickets, X-linked hypophosphatemia, vitamin D-resistant rickets)	primary hypophosphatemic rickets	Intervention name : Z-521 Dosage And administration of the intervention : 300-3000mg inorganic phosphorus is orally administered in 3 or 4 times per day	Zeria Pharmaceutical Co., Ltd.	NULL		1	14	BOTH	10	Phase 3	NULL
2	NCT01237288 (ClinicalTrials.gov)	September 2010	7/11/2010	Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets	Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets	Primary Hypophosphatemic Rickets	Drug: Z-521	Zeria Pharmaceutical	NULL	Completed	1 Year	14 Years	Both	16	Phase 3	Japan